Advertisement
Research Article| Volume 8, ISSUE 2, P77-86, 1981

Differences in Physicochemical Properties Between Tissue Plasminogen Activators from Human Paranasal Mucous Membrane and Pig Heart

DOI:https://doi.org/10.1016/S0385-8146(81)80004-1
Differences in Physicochemical Properties Between Tissue Plasminogen Activators from Human Paranasal Mucous Membrane and Pig Heart
Previous ArticleSerum Complement Levels in Patients with Head and Neck Cancer
Next ArticleA Study of Experimental Sinusitis in Rabbits
      This paper is only available as a PDF. To read, Please Download here.
      In order to clarify the physicochemical property of tissue plasminogen activator (TA), tissue extracts of human paranasal mucous membrane and pig heart were studied by the biochemical techniques. The studies by gel filtration revealed that two plasminogen activators of different molecular weight were present in the extract of human paranasal mucous membrane. The existence of tissue plasminogen activator with a low molecular weight (LMW-TA) has not previously been reported. This molecular weight of this compound was lower than that of cytochrome c. On the other hand, the molecular weight of tissue plasminogen activator from pig heart (PH-TA) was similar to that of ovalbumin, about 46,000 daltons, as estimated by Sephadex G-150 gel filtration. From the physicochemical property of LMW-TA, it is suggested that the LMW-TA from paranasal mucous membrane with chronic sinusitis was produced by proteases, i.e. trypsin-like enzyme, present in the mucous membrane with chronic inflammation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Auris Nasus Larynx
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Albrechtsen O.K.
        • Thaysen J.H.
        Fibrinolytic activity in human saliva.
        Acta Physiol. Scand. 1955; 34: 138-145
        • Ali S.Y.
        • Evans L.
        Purification of rabbit kidney cytokinase and a comparison of its properties with human urokinase.
        Biochem. J. 1968; 107: 293-303
        • Astrup T.
        Tissue activators of plasminogen.
        Fed. Proc. 1966; 25: 42-51
        • Astrup T.
        • Müllertz S.
        The fibrin plate method for estimating fibrinolytic activity.
        Arch. Biochem. Biophys. 1952; 40: 346-351
        • Astrup T.
        • Sterndorff I.
        Fibrinolytic activity of tissue extracts and of trypsin.
        Nature. 1952; 170: 981
        • Bachmann F.
        • Fletcher A.P.
        • Alkjaersig N.
        • Sherry S.
        Partial purification and properties of the plasminogen activator from pig heart.
        Biochemistry. 1964; 3: 1578-1585
        • Cartwright T.
        Partial purification of a specific plasminogen activator from porcine parotid glands.
        Thromb. Diath. Haemorrh. 1974; 31: 403-414
        • Cellander D.R.
        • Guest M.M.
        The biochemistry and physiology of urokinase.
        Am. J. Card. 1960; 6: 409-419
        • Cole E.R.
        • Bachmann F.W.
        Purification and properties of a plasminogen activator from pig heart.
        J. Biol. Chem. 1977; 252: 3729-3737
        • Deutsch D.G.
        • Mertz E.T.
        Plasminogen, purification from human plasma by affinity chromatography.
        Science. 1970; 170: 1095-1096
        • Dixon M.
        A nomogram for ammonium sulfate solutions.
        Biochem. J. 1953; 54: 457-458
        • Flodin C.
        • Killander J.
        Fractionation of human serum proteins by gel filtration.
        Biochim. Biophys. Acta. 1963; 63: 403-410
        • Fujimoto K.
        Some properties of the tissue plasminogen activator from the pig heart and ovary.
        Acta Haem. Jpn. (in Japanese). 1975; 38: 132-142
        • Henderson B.W.
        • Horwitz D.L.
        • Astrup T.
        Release of plasminogen activator from viable leukocytes of man, baboon, dog and rabbits.
        Exp. Biol. Med. 1972; 141: 634-638
        • Hijikata A.
        • Fujimoto K.
        • Kitaguchi H.
        • Okamoto S.
        Some properties of the tissue plasminogen activator from the pig heart.
        Thromb. Res. 1974; 4: 731-740
        • Kosugi T.
        • Matsuo O.
        • Mihara H.
        • Hamaya M.
        Study of plasminogen tissue activator in paranasal mucous membrane.
        J. Jpn. Rhin. Soc. (in Japanese). 1977; 16: 92-93
        • Kosugi T.
        • Morimitsu T.
        • Matsuo O.
        • Mihara H.
        A protease-antiprotease system in antrochoanal polyp. I. Evidence for the existence of proactivator.
        Arch. Otorhinolaryngol. 1979; 225: 97-102
        • Kosugi T.
        • Morimitsu T.
        • Matsuo O.
        • Mihara H.
        Fibrinolytic enzyme in tracheobronchial secretion of rats—Existence of plasminogen activator—.
        Laryngoscope. 1980; 90: 309-315
        • Matsuda M.
        • Iwanaga S.
        • Nakamura S.
        A simple, large scale method for preparation of plasminogen-free fibrinogen.
        Thromb. Res. 1972; 1: 619-632
        • Matsumoto M.
        • Igarashi M.
        • Moroi M.
        • Urita Y.
        • Takeuchi S.
        • Asada T.
        Assay of plasma plasmin and plasminogen by affinity chromatography.
        J. Med. Soc. Toho (in Japanese). 1973; 20: 83-87
        • Miura M.
        Activators and proactivator of fibrinolytic system in paranasal mucous membrane of man.
        Kobe J. Med. Sci. 1965; 11: 13-21
        • Okamoto U.
        • Nagamatsu Y.
        • Matsumoto M.
        Studies on a plasminogen activating system in human milk. 1. Isolation of plasminogen activator and proactivator from human milk, and estimation of their molecular weights.
        Acta Haem. Jpn. 1974; 37: 57-67
        • Okanishi N.
        Fibrinolysis in nasal and paranasal mucous membrane.
        Practica Otologica (Kyoto) (in Japanese). 1975; 68: 427-479
        • Oshiba S.
        • Ariga T.
        Purification and characterization of bilokinase, a biliary plasminogen activator.
        Thromb. Diath. Haemorrh. 1975; 34: 319
        • Rickli E.E.
        • Zaugg H.
        Isolation and purification of highly enriched tissue plasminogen activator from pig heart.
        Thromb. Diath. Haemorrh. 1970; 23: 64-76
        • Rijken D.C.
        • Wijngaards G.
        • Zaal-De Jong M.
        • Welbergen J.
        Purification and partial characterization of plasminogen activator from human uterine tissue.
        Biochim. Biophys. Acta. 1979; 580: 140-153
        • Sasaki Y.
        The electrophoretic analysis of the nasal fibrinolytic enzyme.
        Acta Oto-Laryng. 1968; 65: 346-358
        • Sasaki Y.
        • Okamoto S.
        • Ohwada K.
        • Nishibata T.
        Some observations on a remarkable fibrinolytic activity in the extract of nasal tissues and related tissue.
        Keio J. Med. 1959; 8: 235-246
        • Sgouris J.T.
        • Inman J.K.
        • McCall K.B.
        The preparation of urokinase.
        Am. J. Biol. 1960; 6: 406-408
        • Soszka T.
        Partial purification and some properties of the tissue plasminogen activator from the human myometrium.
        Thromb. Res. 1977; 10: 823-832
        • Vassalli J.D.
        • Reich E.
        Macrophage plasminogen activator induction by products of activated lymphoid cells.
        J. Exp. Med. 1977; 145: 429-437
        • Werb Z.
        Biochemical action of glucocorticoids on macrophages in culture. Specific inhibitor of elastase, collagenase and plasminogen activator secretion and effects on other metabolic functions.
        J. Exp. Med. 1978; 147: 1695-1712

      Article info

      Publication history

      Received: April 1, 1981

      Identification

      DOI: https://doi.org/10.1016/S0385-8146(81)80004-1

      Copyright

      © 1981 Society for Promotion of International Otorhinolaryngology (SPIO). Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX